Modulation of NADPH oxidase activity by known uraemic retention solutes.

about

Modulation of NADPH oxidase activity by known uraemic retention solutes.

Item

http://www.wikidata.org/entity/Q46864424

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@en

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@nl

type

Item

label

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@en

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@nl

prefLabel

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@en

Modulation of NADPH oxidase activity by known uraemic retention solutes.

@nl

P1476

Modulation of NADPH oxidase activity by known uraemic retention solutes

@en

P2093

Anna Marta Schulz

http://www.w3.org/2001/XMLSchema#string

Cindy Terne

http://www.w3.org/2001/XMLSchema#string

Desiree Kunkel

http://www.w3.org/2001/XMLSchema#string

European Uremic Toxin Work Group (EUTox)

http://www.w3.org/2001/XMLSchema#string

Falko Boehringer

http://www.w3.org/2001/XMLSchema#string

Gerald Cohen

http://www.w3.org/2001/XMLSchema#string

Joachim Jankowski

http://www.w3.org/2001/XMLSchema#string

Mandy Schaefer

http://www.w3.org/2001/XMLSchema#string

Vera Jankowski

http://www.w3.org/2001/XMLSchema#string

Walter Zidek

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients.

NADPH oxidases: functions and pathologies in the vasculature.

Role of oxidative stress in cardiovascular diseases.

Review on uremic toxins: classification, concentration, and interindividual variability.

Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression.

P304

802-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.12297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Martin Tepel

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25041433

http://www.w3.org/2001/XMLSchema#string